BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Apoptosis, HIV infection, Pancreas, Nosology, Aspirin, rs2230926, PBX1)
Bookmark Forward

QuickView for negative regulation of growth of symbiont in host (biogroup)


Body Atlas

Most Correlated Tissues

  1. Bone marrow
  2. Fetal liver
  3. Accumbens
  4. Granulocyte-macrophage progenitor cell of bone marrow
  5. Cerebellar hemisphere
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Social environment related disease
  2. Legionella infection
  3. Infection due to Staphylococcus aureus
  4. Disease due to Rotavirus
  5. Coronavirus infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. niguldipine
  2. CGP 60474
  3. CP 724714
  4. A 443654
  5. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. METTL4
  2. ANKRD2
  3. SGPL1
  4. TLR5
  5. HOXB4
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  3. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
  4. L1000 CMAP - Kidney epithelial HA1E.101 cells with CRISPR targeted gene knockouts
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for negative regulation of growth of symbiont in host
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for negative regulation of growth of symbiont in host
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.